News

The drug met its primary endpoints in a Chinese trial, while a Phase III trial in Sjögren's syndrome is currently underway in ...
China-based RemeGen has announced that its global first-in-class BLyS (BAFF)/APRIL dual-target fusion protein drug, ...
World No. 1 Jannik Sinner has yet to drop a set at the Cincinnati Open heading into the quarterfinals. Sinner will face Felix ...
Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 3 study titled ‘A Phase 3 Randomized, ...
Coco Gauff advanced to the fourth round of the Cincinnati Open after her opponent withdrew due to illness. Gauff will have ...
Venus Williams is back on the professional tennis tour at age 45 and will be returning to the U.S. Open next week for her ...
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb is conducting a ...
Venus Williams is back on the professional tennis tour at age 45 and will be returning to the U.S. Open next week for her ...
Bristol-Myers Squibb Company announced a significant update in their Sjögren’s Syndrome study. The Phase 3 study tests ...
VENUS Williams is back on the professional tennis tour at age 45 and will be returning to the US Open next week for her first ...